Cite
HARVARD Citation
Tada, T. et al. (2020). Platelet–lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysis. European journal of gastroenterology & hepatology. 32 (2), pp. 261-268. [Online].